Excite Medical’s DRX9000-SL wins Australian clearance

Excite Medical’s DRX9000-SL spinal decompression system has been added to Australia’s Therapeutic Goods Register, clearing the device for sale there as a Class IIa medical device. The move expands access to a non-surgical treatment option for patients with chronic low back pain, sciatica and related spinal conditions.

Why it matters: - Australia’s clearance opens another regulated market for Excite Medical’s DRX9000-SL, expanding access to a non-surgical spinal decompression option. - The listing gives healthcare providers in Australia a device cleared for use in treating pain and disability tied to low back pain, sciatica and other degenerative spine conditions. - The company is positioning the system as a treatment option before spine surgery is considered.

What happened: - Excite Medical said the DRX9000-SL has been included in the Australian Register of Therapeutic Goods. - The listing allows the system to be supplied throughout Australia as a Class IIa medical device. - The ARTG entry identifies the DRX9000-SL as a True Non-Surgical Spinal Decompression System. - The approved intended purpose covers management of pain and disability associated with incapacitating low back pain and sciatica. - The device is designed to apply spinal decompressive forces to compressive and degenerative injuries of the spine.

The details: - Excite Medical said the clearance followed work across engineering, software development, quality systems, regulatory compliance and independent product testing. - The company completed third-party evaluation to internationally recognized medical electrical equipment standards. - The DRX9000-SL includes advanced automation, intelligent treatment programming, enhanced treatment workflows and multi-disc level targeting technologies. - Excite Medical said the system is built on the clinically researched DRX9000 platform. - The company said the DRX9000-SL is supported by multiple U.S. patent applications that have received Notices of Allowance, along with other pending U.S. and international applications. - TÜV SÜD America evaluated compliance with standards covering electrical safety, mechanical safety, patient protection, risk management, usability engineering and essential performance. - Excite Medical maintains an MDSAP-certified quality management system.

Between the lines: - The Australian clearance suggests the company is using regulatory approvals and test data to push broader international commercialization. - Excite Medical is framing the DRX9000-SL as an evolution of an older platform rather than a standalone replacement. - The company is leaning on published clinical research to distinguish the product from newer spinal care technologies that lack long-term evidence. - Saleem Musallam said the DRX9000-SL is the most significant evolution in non-surgical spinal decompression technology in more than 20 years. - Musallam said innovation is the company’s responsibility and that Excite Medical continues to invest in clinical research, engineering and product development.

What’s next: - Excite Medical said Australia joins a growing number of countries where providers can offer the DRX9000-SL as part of non-surgical spine care. - The company is likely to keep pursuing international commercialization as additional patent and regulatory work continues. - Further adoption will depend on provider uptake and how the device is positioned against other conservative treatment options.

The bottom line: - The DRX9000-SL’s Australian listing gives Excite Medical another foothold abroad and strengthens its case for the device as a regulated, evidence-backed non-surgical spine treatment.